Alterations in plasma complement levels after human ischemic stroke

Neurosurgery

Volumn 59, Issue 1, 2006, Pages 28-32

  Mocco, J ^a   Wilson, David A ^a   Komotar, Ricardo J ^a   Sughrue, Michael E ^a   Coates, Kristen ^a   Sacco, Ralph L ^b   Elkind, Mitchell S V ^b   Connolly Jr , E Sander ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

Author keywords

Complement; Human; Ischemic; Plasma; Stroke

Indexed keywords

COMPLEMENT; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5B;

ADULT; AGED; ARTICLE; BLOOD; BLOOD LEVEL; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DATA ANALYSIS; ETHNOLOGY; FEMALE; HUMAN; MALE; PARAMETER; POPULATION RESEARCH; PRIORITY JOURNAL; RACE; RANK SUM TEST; SEX RATIO; STATISTICAL ANALYSIS; STROKE;

AGED; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; CEREBROVASCULAR ACCIDENT; COMPLEMENT ACTIVATION; COMPLEMENT C3A; COMPLEMENT C5A; COMPLEMENT MEMBRANE ATTACK COMPLEX; FEMALE; HUMANS; MALE; MIDDLE AGED; OSMOLAR CONCENTRATION; TIME FACTORS;

EID: 33745803889     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000219221.14280.65     Document Type: Article

References (33)

1. Akita N, Nakase H, Kanemoto Y, Kaido T, Nishioka T, Sakaki T: The effect of C 1 esterase inhibitor on ischemia: Reperfusion injury in the rat brain [in Japanese]. No to Shinkei 53:641-644, 2001.
2. Arumugam TV, Shiels IA, Woodruff TM, Granger DN, Taylor SM: The role of the complement system in ischemia-reperfusion injury. Shock 21:401-409, 2004.
3. Cannon RO 3rd: Mechanisms, management and future directions for reperfusion injury after acute myocardial infarction. Nat Clin Pract Cardiovasc Med 2:88-94, 2005.
4. Cerqueira NF, Hussni CA, Yoshida WB: Pathophysiology of mesenteric ischemia/reperfusion: A review. Acta Cir Bras 20:336-343, 2005.
5. Cowell RM, Plane JM, Silverstein FS: Complement activation contributes to hypoxic-ischemic brain injury in neonatal rats. J Neurosci 23:9459-9468, 2003.
6. D'Ambrosio AL, Pinsky DJ, Connolly ES Jr: The role of the complement cascade in ischemia/reperfusion injury: Implications for neuroprotection. Mol Med 7:367-382, 2001.
7. De Simoni MG, Storini C, Barba M, Catapano L, Arabia AM, Rossi E, Bergamaschini L: Neuroprotection by complement (C1) inhibitor in mouse transient brain ischemia. J Cerebral Blood Flow Metab 23:232-239, 2003.
8. Di Napoli M: Systemic complement activation in ischemic stroke. Stroke 32:1443-1448, 2001.
9. Dirnagl U, Iadecola C, Moskowitz MA: Pathobiology of ischaemic stroke: An integrated view. Trends Neurosci 22:391-397, 1999.
10. Ember JA, Jagels MA, Hugli TE, Volanakis JE (eds): The Human Complement System in Health and Disease. New York, Marcel Dekker, 1998, pp 241-284.
11. Enlimomab Acute Stroke Trial Investigators: Use of anti-ICAM-1 therapy in ischemic stroke: Results of the Enlimomab Acute Stroke Trial. Neurology 57:1428-1434, 2001.
12. Fishelson Z, Attali G, Mevorach D: Complement and apoptosis. Mol Immunol 38:207-219, 2001.
13. Fisher M: Recommendations for standards regarding preclinical neuroprotective and restorative drug development. Stroke 30:2752-2758, 1999.
14. Fisher M: Recommendations for advancing development of acute stroke therapies: Stroke Therapy Academic Industry Roundtable 3. Stroke 34:1539-1546, 2003.
15. Fisher M, Ratan R: New perspectives on developing acute stroke therapy. Ann Neurol 53:10-20, 2003.
16. Gladstone DJ, Black SE, Hakim AM: Toward wisdom from failure: Lessons from neuroprotective stroke trials and new therapeutic directions. Stroke 33:2123-2136, 2002.
17. Huang J, Kim LJ, Mealey R, Marsh HC Jr, Zhang Y, Tenner AJ, Connolly ES Jr, Pinsky DJ: Neuronal protection in stroke by an sLex-glycosylated complement inhibitory protein. Science 285:595-599, 1999.
18. Iltumur K, Karabulut A, Toprak G, Toprak N: Complement activation in acute coronary syndromes. Apmis 113:167-174, 2005.
19. Lee KR, J. Zivin T, Ashwood A, Davalos S, Davis HC, Diener J, Grotta P, Lyden A, Shuaib W: Preliminary results of Saint-1 trial. Presented at the 14th European Stroke Conference, Bologna, Italy, May 28, 2005.
20. Mastellos D, Papadimitriou JC, Franchini S, Tsonis PA, Lambris JD: A novel role of complement: Mice deficient in the fifth component of complement (C5) exhibit impaired liver regeneration. J Immunol 166:2479-2486, 2001.
21. Mevorach D: The immune response to apoptotic cells. Annal N Y Acad Sci 887:191-198, 1999.
22. Mevorach D: Opsonization of apoptotic cells. Implications for uptake and autoimmunity. Annal N Y Acad Sci 926:226-235, 2000.
23. Mevorach D: Systemic lupus erythematosus and apoptosis: A question of balance. Clin Rev Allergy Immunol 25:49-60, 2003.
24. Mevorach D, Mascarenhas JO, Gershov D, Elkon KB: Complement-dependent clearance of apoptotic cells by human macrophages. J Exp Med 188:2313-2320, 1998.
25. Nijmeijer R, Krijnen PA, Assink J, Klaarenbeek MA, Lagrand WK, Veerhuis R, Visser CA, Meijer CJ, Niessen HW, Hack CE: C-reactive protein and complement depositions in human infarcted myocardium are more extensive in patients with reinfarction or upon treatment with reperfusion. Eur J Clin Invest 34:803-810, 2004.
26. Onat A, Uzunlar B, Hergenc G, Yazici M, Sari I, Uyarel H, Can G, Sansoy V: Cross-sectional study of complement C3 as a coronary risk factor among men and women. Clin Sci (Lond) 108:129-135, 2005.
27. Pedersen ED, Waje-Andreassen U, Vedeler CA, Aamodt G, Mollnes TE: Systemic complement activation following human acute ischaemic stroke. Clin Exp Immunol 137:117-122, 2004.
28. Sacco RL, Elkind M, Boden-Albala B, Lin IF, Kargman DE, Hauser WA, Shea S, Paik MC: The protective effect of moderate alcohol consumption on ischemic stroke. JAMA 281:53-60, 1999.
29. Szeplaki G, Prohaszka Z, Duba J, Rugonfalvi-Kiss S, Karadi I, Kokai M, Kramer J, Fust G, Kleiber M, Romics L, Varga L: Association of high serum concentration of the third component of complement (C3) with pre-existing severe coronary artery disease and new vascular events in women. Atherosclerosis 177:383-389, 2004.
30. Tamam Y, Iltumur K, Apak I: Assessment of acute phase proteins in acute ischemic stroke. Tohoku J Exp Med 206:91-98, 2005.
31. Ten VS, Sosunov SA, Mazer SP, Stark RI, Caspersen C, Sughrue ME, Botto M, Connolly ES Jr, Pinsky DJ: C1q-deficiency is neuroprotective against hypoxic-ischemic brain injury in neonatal mice. Stroke 36:2244-2250, 2005.
32. Vasthare US, Barone FC, Sarau HM, Rosenwasser RH, DiMartino M, Young WF, Tuma RF: Complement depletion improves neurological function in cerebral ischemia. Brain Res Bull 45:413-419, 1998.
33. Vuorte J, Lindsberg PJ, Kaste M, Meri S, Jansson SE, Rothlein R, Repo H: Anti-ICAM-1 monoclonal antibody R6.5 (Enlimomab) promotes activation of neutrophils in whole blood. J Immunol 162:2353-2357, 1999.